Rexulti (generic: brexpiprazole) is an oral atypical antipsychotic medication used to treat schizophrenia and major depressive disorder. Other atypical antipsychotics include Abilify (aripiprazole), Zyprexa (olanzapine), Seroquel (quetiapine) and Geodon (ziprasidone). Rexulti is manufactured by Otsuka America Pharmaceutical, Inc., and was approved by the U.S. Food & Drug Administration (FDA) on July 10, 2015.
Unfortunately, Rexulti has been linked to the increased risk of uncontrollable impulse control disorders like compulsive gambling, shopping, eating, and sex addiction/hypersexuality.
If you have suffered from addictive gambling behavior after taking Rexulti, YOU ARE NOT ALONE.
FDA Study Links Rexulti to Compulsive Behaviors
A recent study by the FDA found compulsions to be a rare but serious side effect of Rexulti. Among 2,627 participants who had side effects from Rexulti, at least 3 reported some form of compulsive behavior. All 3 patients had initiated treatment with the drug 6 months or less at the time symptoms first appeared, the study found.
Rexulti Side Effects
Our lawyers are representing people who were prescribed Rexulti and subsequently suffered financial loss due to uncontrollable gambling.
According to Drugs.com, frequent Rexulti side effects include anxiety, dizziness, drowsiness, dyspepsia, fatigue, increased creatine phosphokinase in blood specimen, nasopharyngitis, tremor, weight gain, hypersomnia, and sedated state. Visit their website to learn more.
Abilify vs. Rexulti: A Case of Pharmaceutical Evergreening?
Pharmaceutical evergreening is a marketing strategy used by manufacturers to generate additional profits after a medication’s patent has expired. The patent-holder tweaks the original drug and then patents the new version. In some cases, the new drug has genuine advantages, but often evergreening is motivated by financial incentives.
Critics have pointed to a case of evergreening with Abilify and Rexulti, which are manufactured by Otsuka America Pharmaceutical, Inc., and work basically the same, although each has a distinct pharmacological profile. Otsuka claims Rexulti is an improvement on Abilify, but this has yet to be proven.
The manufacturers of a similar drug, Abilify (Bristol-Myers Squibb and Otsuka Pharmaceutical Co.) agreed in early 2019 to a confidential settlement in a number of gambling lawsuits.
Do I Have a Rexulti Lawsuit? Contact a Lawyer Today.
The Class Action & Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Rexulti lawsuits. We are handling individual litigation nationwide and currently handling Rexulti gambling cases in all 50 states.
Again, if you or somebody you know has suffered from gambling losses after taking Rexulti, you may be entitled to financial compensation by filing an Rexulti lawsuit.
Our lawyers offer a free review of your potential case. Please use the form below to contact us today.